Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pyxis Oncology (PYXS) Cash from Operations (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Cash from Operations for 2 consecutive years, with 10427000.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations rose 45.95% to 10427000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 63502000.0 through Dec 2025, down 10.11% year-over-year, with the annual reading at 63502000.0 for FY2025, 10.11% down from the prior year.
  • Cash from Operations for Q4 2025 was 10427000.0 at Pyxis Oncology, up from 13277000.0 in the prior quarter.
  • The five-year high for Cash from Operations was 3007000.0 in Q2 2024, with the low at 22535000.0 in Q1 2025.